Expertise in
5
conditions

Kelvin W. To

State Key Laboratory Of Emerging Infectious Diseases, 
Hong Kong Special Administrative Region, CN 
Expertise in
5
conditions
State Key Laboratory Of Emerging Infectious Diseases, 
Hong Kong Special Administrative Region, CN 

Overview

Kelvin To practices practicing medicine in Hong Kong Special Administrative Region, China.

To is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Flu, Avian Influenza, Severe Acute Respiratory Syndrome (SARS), and COVID-19.

They are actively involved in clinical research, co-authoring 119 peer reviewed articles and participating in 5 clinical trials.

Locations

State Key Laboratory Of Emerging Infectious Diseases, Hong Kong Special Administrative Region, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Open-label Randomized Controlled Trial on Interferon β-1b and Hydroxychloroquine Combination Versus Hydroxychloroquine Alone, as Treatment for COVID-19 Infection
An Open-label Randomized Controlled Trial on Interferon β-1b and Hydroxychloroquine Combination Versus Hydroxychloroquine Alone, as Treatment for COVID-19 Infection
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 2
An Open-label Randomized Controlled Trial on Lopinavir/ Ritonavir, Ribavirin and Interferon Beta 1b Combination Versus Lopinavir/ Ritonavir Alone, as Treatment for 2019 Novel Coronavirus Infection
An Open-label Randomized Controlled Trial on Lopinavir/ Ritonavir, Ribavirin and Interferon Beta 1b Combination Versus Lopinavir/ Ritonavir Alone, as Treatment for 2019 Novel Coronavirus Infection
Enrollment Status: Completed
Publish Date: April 15, 2020
Intervention Type: Drug
Study Phase: Phase 2
Efficacy and Safety of a Novel Intradermal Live-attenuated Varicella Zoster Vaccine in Hematopoietic Stem Cell Transplantation Donors: a Randomized Double Blind Placebo-controlled Trial
Efficacy and Safety of a Novel Intradermal Live-attenuated Varicella Zoster Vaccine in Hematopoietic Stem Cell Transplantation Donors: a Randomized Double Blind Placebo-controlled Trial
Enrollment Status: Completed
Publish Date: October 24, 2019
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
Efficacy of Intradermal Hepatitis B Vaccine in Renal Failure Patients
Efficacy of Intradermal Hepatitis B Vaccine in Renal Failure Patients
Enrollment Status: Completed
Publish Date: October 22, 2019
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
A Randomized Controlled Trial on the Treatment of Severe Influenza A Infection
A Randomized Controlled Trial on the Treatment of Severe Influenza A Infection
Enrollment Status: Completed
Publish Date: October 21, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

119 Total Publications

Cardiovascular-Kidney-Metabolic (CKM) Syndrome as Independent Risk Factor for Pneumococcal Pneumonia: Evidence from a Territory-Wide Study.
Cardiovascular-Kidney-Metabolic (CKM) Syndrome as Independent Risk Factor for Pneumococcal Pneumonia: Evidence from a Territory-Wide Study.
Journal: Microorganisms
Published: January 13, 2026

Frequently Asked Questions about Kelvin W. To

Is Kelvin W. To a top-rated expert for Flu?

MediFind is an objective health platform that identifies experts based on real-world data. Kelvin W. To is classified as an Distinguished expert for Flu, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Kelvin W. To participate in research or clinical trials?

Yes. Kelvin W. To has published 119 articles and abstracts on conditions like Flu. You can view a list of Kelvin W. To's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find To's expertise for a condition
ConditionClose
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile